The Role of Platelet Indices in Predicting Short-Term Mortality in Elderly Patients with Pulmonary Embolism

Yıl 2021, Cilt: 11 Sayı: 6, 833 - 837, 20.11.2021

Serdar Özdemir Abdullah Algın

https://doi.org/10.16899/jcm.988406

Cited By: 4

Öz

Objective: This study aimed to investigate the role of platelet count, mean platelet volume (MPV), plateletcrit, platelet distribution width (PDW), platelet mass index (PMI), and MPV-to-platelet count ratio (MPR) in predicting short-term mortality in patients aged 65 and over with pulmonary embolism.
Methods: This retrospective, observational, cohort study included corrected pulmonary embolism patients. Demographics, clinical characteristics, and platelet indices and the data of all-cause mortality within 30 days after admission were noted. The receiver operating characteristic curve analysis and multivariate analysis was performed to determine the discriminative ability of the scores.
Results: A final analysis of 128 patients was performed. The mortality rate was 21.8%. There was no significant relationship in the multivariate analysis between mortality and platelet indices (Mann-Whitney U test). Area under curves of neutrophil-to-lymphocyte ratio, PMI, MPR, plateletcrit, platelet count, and MPV are 0.501, 0.640, 0.626, 0.642, 0.633, and 0.532, respectively.
Conclusion
As a conclusion based on results of our simple, platelet indices could not predict short-term mortality in elderly patients with pulmonary embolism.

Anahtar Kelimeler

Blood Platelets, Pulmonary embolism, Mean Platelet Volume, Mortality

Pulmoner Embolisi Olan Yaşlı Hastalarda Kısa Süreli Mortaliteyi Öngörmede Trombosit İndekslerinin Rolü

Öz

Amaç: Bu çalışmada trombosit sayısı, ortalama trombosit hacmi (MPV), plateletkrit, trombosit dağılım genişliği (PDW), trombosit kitle indeksi (PMI) ve MPV-trombosit sayı oranının (MPR) pulmoner emboli olan 65 yaş ve üstü hastalarda kısa dönem mortaliteyi öngörmedeki rolü araştırıldı.
Yöntemler: Retrospektif, gözlemsel, kohort çalışmamıza, radyolojik olarak doğrulanmış pulmoner emboli hastaları dahil edildi. Başvurudan sonraki 30 gün içinde tüm nedenlere bağlı ölüm verileri, demografik özellikler, klinik özellikler ve trombosit indeksleri ve kaydedildi. Torombosit indekslerinin öngörebilirliğini belirlemek için alıcı işletim karakteristik eğrisi analizi ve çok değişkenli analiz yapıldı.
Bulgular: 128 hastanın son analizi yapıldı. Ölüm oranı %21,8 idi. Mortalite ile trombosit indeksleri arasında çok değişkenli analizde anlamlı bir ilişki yoktu (Mann-Whitney U testi). Nötrofil-lenfosit oranı, PMI, MPR, trombositkrit, trombosit sayısı ve MPV eğrilerinin altında kalan alan sırasıyla 0,501, 0,640, 0,626, 0,642, 0,633 ve 0,532' idi.
Sonuç: Örneklemimizin sonuçlarına göre, trombosit indeksleri pulmoner embolisi olan yaşlı hastalarda kısa dönem mortaliteyi öngörmede kullanılamaz.

Anahtar Kelimeler

Kan Trombositleri, Pulmoner emboli, Ortalama Trombosit Hacmi, Mortalite

Kaynakça

• 1- Turetz M, Sideris AT, Friedman OA, Triphathi N, Horowitz JM. Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism. Semin Intervent Radiol. 2018;35(2):92-98. doi:10.1055/s-0038-1642036
• 2- Opitz I, Ulrich S. Chronic thromboembolic pulmonary hypertension. Swiss Med Wkly. 2018 Dec 21;148:w14702. doi: 10.4414/smw.2018.14702. PMID: 30576568.
• 3- Surov A, Akritidou M, Bach AG, Bailis N, Lerche M, Meyer HJ, Pech M, Wienke A. A New Index for the Prediction of 30-Day Mortality in Patients With Pulmonary Embolism: The Pulmonary Embolism Mortality Score (PEMS). Angiology. 2021 Sep;72(8):787-793. doi: 10.1177/0003319721993346. Epub 2021 Feb 9. PMID: 33557585; PMCID: PMC8326960.
• 4- Periayah MH, Halim AS, Mat Saad AZ. Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis. Int J Hematol Oncol Stem Cell Res. 2017;11(4):319-327.
• 5- Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002 May 27;162(10):1182-9. doi: 10.1001/archinte.162.10.1182. PMID: 12020191.
• 6- Budak YU, Polat M, Huysal K. The use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: a systematic review. Biochem Med (Zagreb). 2016;26(2):178-193. doi:10.11613/BM.2016.020
• 7- Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway. J Thromb Haemost. 2010 Jan;8(1):157-62. doi: 10.1111/j.1538-7836.2009.03498.x. 8- Yun SH, Sim EH, Goh RY, Park JI, Han JY. Platelet Activation: The Mechanisms and Potential Biomarkers. Biomed Res Int. 2016;2016:9060143. doi:10.1155/2016/9060143
• 9- Thon JN, Montalvo A, Patel-Hett S, Devine MT, Richardson JL, Ehrlicher A, Larson MK, Hoffmeister K, Hartwig JH, Italiano JE Jr. Cytoskeletal mechanics of proplatelet maturation and platelet release. J Cell Biol. 2010 Nov 15;191(4):861-74. doi: 10.1083/jcb.201006102.
• 10- Lin W, Wu Y, Lu X, Hu Y. Association between mean platelet volume and pulmonary embolism: a systematic review and meta-analysis. Aging (Albany NY). 2021 Jul 2;13(13):17253-17273. doi: 10.18632/aging.203205.
• 11- Ren ZJ, Ren PW, Yang B, Liao J, Liu SZ, Lu DL, Wei X, Liu LR, Dong Q. Mean platelet volume, platelet distribution width and platelet count in erectile dysfunction: A systematic review and meta-analysis. Andrologia. 2017 Dec;49(10). doi: 10.1111/and.12777
• 12- Kahvecioglu D, Erdeve O, Akduman H, Ucar T, Alan S, Çakır U, Yıldız D, Atasay B, Arsan S, Atalay S. Influence of platelet count, platelet mass index, and platelet function on the spontaneous closure of ductus arteriosus in the prematurity. Pediatr Neonatol. 2018 Feb;59(1):53-57. doi: 10.1016/j.pedneo.2017.01.006.
• 13- Okur N, Buyuktiryaki M, Uras N, Oncel MY, Ertekin O, Canpolat FE, Oguz SS. Platelet mass index in very preterm infants: can it be used as a parameter for neonatal morbidities? J Matern Fetal Neonatal Med. 2016 Oct;29(19):3218-22. doi: 10.3109/14767058.2015.1121475.
• 14- Korkmaz L, Baştuğ O, Ozdemir A, Korkut S, Karaca C, Akin MA, Gunes T, Kurtoglu S, Ozturk MA. The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index. Curr Eye Res. 2017 Jan;42(1):88-97. doi: 10.3109/02713683.2016.1158272.
• 15- Zhong Q, Peng J. Mean platelet volume/platelet count ratio predicts severe pneumonia of COVID-19. J Clin Lab Anal. 2021;35(1):e23607. doi:10.1002/jcla.23607
• 16- Ates H, Ates I, Kundi H, Yilmaz FM. Diagnostic validity of hematologic parameters in evaluation of massive pulmonary embolism. J Clin Lab Anal. 2017 Sep;31(5):e22072. doi: 10.1002/jcla.22072.
• 17- Erdal E, İnanir M. Platelet-to-lymphocyte ratio (PLR) and Plateletcrit (PCT) in young patients with morbid obesity. Rev Assoc Med Bras (1992). 2019 Oct 10;65(9):1182-1187. doi: 10.1590/1806-9282.65.9.1182. PMID: 31618335.
• 18- Çakmak HA, Enhoş A, Ertürk M, Kalkan AK, Satılmışoğlu MH, Gül M. Association Between New Platelet Indices and Calcific Aortic Stenosis: Plateletcrit And Platelet to Lymphocyte Ratio. Van Med J. 2016; 23(4): 330-7.
• 19- Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47-58. doi: 10.2174/138161211795049804.
• 20- Sevuk U, Bahadir MV, Altindag R, Baysal E, Yaylak B, Ay N, Ayaz F, Demirtas E. Value of serial platelet indices measurements for the prediction of pulmonary embolism in patients with deep venous thrombosis. Ther Clin Risk Manag. 2015 Aug 20;11:1243-9. doi: 10.2147/TCRM.S89355. PMID: 26316769; PMCID: PMC4548763.